PDF (2.3 MB)
Collect
Submit Manuscript
Show Outline
Outline
Abstract
Electronic Supplementary Material
Show full outline
Hide outline
Research Article | Open Access | Just Accepted

Weizmannia coagulans spores alleviates DSS-induced ulcerative colitis model by modulation of gut flora, metabolites and suppressing TLR4/MyD88/NF-κB pathway

Ying Wu1,3Pingping Tian1,2Junfei Li1Han Gao1Shanshan Tie1Shumiao Zhao5Huayi Suo4Shaobin Gu1,2,3()

1 College of Food and Bioengineering, Henan University of Science and Technology, Luoyang, P.R. China.

2 Henan Engineering Research Center of Food Microbiology, Luoyang, P.R. China.

3 National Demonstration Center for Experimental Food Processing and Safety Education, Luoyang, P.R. China.

4 College of Life Science and Technology, Huazhong Agricultural University, Wuhan, P.R. China.

5 College of Food Science, Southwest University, Chongqing, P.R. China.

Show Author Information

Abstract

Ulcerative colitis (UC) is a chronic intestinal inflammatory disease characterized by a complex pathogenesis. Weizmannia coagulans has emerged as a potential probiotic for treating intestinal disorders. This study aimed to assess the therapeutic impact of Weizmannia coagulans BC99 on mice with DSS-induced UC and to elucidate its underlying mechanism of action. Our findings revealed that BC99 administration ameliorated symptoms associated with DSS-induced UC mice, as evidenced by reduced disease activity indexes, reversal of weight loss, and normalization of colon length. Furthermore, BC99 treatment also protected the integrity of the intestinal barrier through maintaining the antioxidant activity and the expression of tight junction proteins (ZO-1 and occluding), and regulating the inflammatory cytokines in DSS-induced UC mice. Additionally, BC99 supplementation enhanced the production of short-chain fatty acids (SCFAs) through the proliferation of SCFA-producing bacteria, including Bidobacterium, Blautia and Faecallbaculum. Notably, the NF-κB signaling pathway was found to be closely related to BC99 treatment in DSS-induced UC mice. The positive protein expression the mRNA expression of TLR4, MyD88 and p65 in colon tissue were all detected in BC99-treated groups, which indicating that BC99 could alleviate UC symptoms by inhibiting TLR4/MyD88/NF-κB signaling pathway. Metabolomics further confirms the previous results. Collectively, these findings provide basic support for the Weizmannia coagulans as a functional food additive or a promising therapeutic agent for the effective management of UC.

Electronic Supplementary Material

Download File(s)
2024-00186.R3_ESM.zip (285.1 KB)
Food Science and Human Wellness
Cite this article:
Wu Y, Tian P, Li J, et al. Weizmannia coagulans spores alleviates DSS-induced ulcerative colitis model by modulation of gut flora, metabolites and suppressing TLR4/MyD88/NF-κB pathway. Food Science and Human Wellness, 2024, https://doi.org/10.26599/FSHW.2024.9250351
Metrics & Citations  
Article History
Copyright
Rights and Permissions
Return